Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...

Tech provider Signant Health announced the acquisition of Ametris to unite its electronic clinical outcome assessments (eCOA) ...

Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...

Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...

Steven Nathan, MD, continues a discussion surrounding the patient journey in through IPF treatment. What is the potential impact of these novel treatments on disease progression, mortality, and ...

New research shows that lymphoma survivors often face long-term peripheral neuropathy, which may be more severe than what ...

The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...

Generally, patient-reported outcomes (PROs) provide complementary information to measured or clinician-assessed functions or symptoms. First, PROs need to be tailored to the specific disorder and, ...

Management of Malignant Pleural Effusion in 2024: A Definitive and Unified Global Approach Interestingly, though, the Danish multicenter randomized study 6 did not reproduce the survival benefit ...

Integration of Telemedicine Consultation Into a Tertiary Radiation Oncology Department: Predictors of Use, Treatment Yield, and Effects on Patient Population Using the scoping review methodology ...

A majority of physicians say the prior authorization process continues to negatively impact patient outcomes and employee ...

Solutions Market, driven by trends toward decentralized, patient-centric clinical trials, is projected to grow from USD 1.94 billion in 2026 to approximately USD 7.46 billion by 2036, at a CAGR of 14.